关键词: COVID‐19 Kikuchi disease Kikuchi‐Fujimoto disease SARS‐CoV‐2 lymphadenopathy maximum

来  源:   DOI:10.1002/rcr2.1414   PDF(Pubmed)

Abstract:
Kikuchi-Fujimoto Disease (KFD), also known as Kikuchi disease or Kikuchi histiocytic necrotizing lymphadenitis, is a rare and self-limiting condition characterized by cervical lymphadenopathy and fever, primarily affecting young Asian adults. The aetiology of KFD remains unknown, although various infectious agents have been suggested as potential triggers. With the emergence of the COVID-19 pandemic, cases of post-COVID-19 KFD and post-COVID-19 vaccine KFD have been reported. In this article, we present the first case of post-COVID-19 KFD in Hong Kong. A 24-year-old man developed fever and painful neck swelling 1 month after recovering from COVID-19. Diagnostic evaluation, including ultrasound-guided fine needle aspiration cytology (FNAC), confirmed the diagnosis of KFD. The patient\'s symptoms resolved spontaneously with supportive care. This case underscores the importance of considering KFD as a potential differential diagnosis in patients presenting with cervical lymphadenopathy and fever following COVID-19 recovery or vaccination.
摘要:
Kikuchi-Fujimoto病(KFD),也称为菊池病或菊池组织细胞坏死性淋巴结炎,是一种罕见的自限性疾病,以颈部淋巴结肿大和发热为特征,主要影响年轻的亚洲成年人。KFD的病因仍然未知,尽管各种感染因子被认为是潜在的触发因素。随着COVID-19大流行的出现,已经报道了COVID-19后KFD和COVID-19疫苗后KFD的病例。在这篇文章中,我们介绍了香港首例后COVID-19KFD病例。一名24岁男子在从COVID-19康复1个月后出现发烧和颈部疼痛性肿胀。诊断评估,包括超声引导的细针穿刺细胞学(FNAC),确诊为KFD。患者的症状通过支持治疗自发缓解。该病例强调了将KFD作为COVID-19康复或接种疫苗后出现颈部淋巴结肿大和发热的患者的潜在鉴别诊断的重要性。
公众号